30 closest matches · ranked by relevance
Frontal Fibrosing Alopecia
Primary: Change in Expression of Chemokine (C-X-C Motif) Ligand 9 (CXCL9), Chemokine (C-X-C Motif) Ligand 10 (CXCL10), and Interferon (IFN)-γ From Baseline to Week 12. — -3.10…
Frontal Fibrosing Alopecia · Lichen Planopilaris of Scalp
Primary: Effectiveness of Oral Tofacitinib in Recalcitrant Frontal Fibrosing Alopecia(FFA) — 47.5; 44; 16.3; 15.9 score on a scale
Fibrosing Alopecia · Frontal Fibrosing Alopecia · Central Centrifugal Cicatricial Alopecia
Primary: Total Area Hair Count (Frontal) — 86.8 Count per cm^2
Lichen Planopilaris · Frontal Fibrosing Alopecia
Primary: Change in Patient-Reported Itch — -0.33 units on a scale
Central Centrifugal Cicatricial Alopecia
Primary: Mean Change in Physician Global Assessment of Improvement (PGA-I) — 0.07 score on a scale
Androgenetic Alopecia
Primary: Target Area Hair Count — 152.7; 158.6; 162.2; 175.7 hairs per centimeter squared — p=<0.0001
Alopecia
Primary: Target Area Hair Count (TAHC) — 167.3; 169.7; 192.8; 194.4 hairs per centimeter squared — p=0.9170
Alopecia
Primary: Hair Density Change After Three Treatments — 175.1 percentage of pre-treatment hair density
Alopecia Areata
Primary: Percentage of Participants With an Absolute Severity of Alopecia Tool (SALT) Score of Less Than or Equal to 20 at Week 24 — 30.65; 22.31; 23.39; 14.29 Percentage of…
Alopecia Areata
Primary: The Proportion of Subjects Achieving at Least a 50% Reduction in Their Scalp Alopecia Areata Severity Scores (SALT Score) From Baseline Values — 8.7; 13.6 percentage of…
Androgenetic Alopecia
Primary: Incidence of Treatment-emergent Adverse Events (Safety) — 0 adverse events
Alopecia Areata
Primary: Number of Patients With SALT50 — 1; 1 Participants
Alopecia Areata
Primary: Change From Baseline in the Severity of Alopecia Tool (SALT) Score at Week 24 — -6.3; 2.3 score on a scale
Alopecia Areata
Primary: Likelihood of Depressive Episodes — 1217; 3576 Participants
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Change in Hair Count at 16 and 26 Weeks Over Baseline — -0.8; 12.5; 3.0; 20.6 hairs per cm^2
Cicatricial Alopecia
Primary: Number of Participants With Treatment-Emergent Adverse Events — 0; 3 Participants
Androgenetic Alopecia · Hair Loss · Female Pattern Baldness
Primary: Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline — 1.3; 14.8; 2.8; 20.2 hairs per cm^2
Androgenic Alopecia
Primary: Scalp Hair Density — 1.46; 2.58; -4.10; 6.68 Change from baseline (No. of hairs/cm2)
Alopecia, Androgenetic
Primary: Safety & Tolerability Assessment of SAE/AE — 5; 9; 12; 2 events
Central Centrifugal Cicatricial Alopecia
Primary: Shape of the Hairline Documented With Photographs — 8; 12; 2 Participants
Androgenetic Alopecia · Coronavirus Disease 2019 · Covid19
Primary: Androgenetic Alopecia Frequency in Participants. — 209; 37; 11; 43 Participants
Alopecia Areata
Primary: Total Number of Participants With At Least 50% Hair Regrowth — 1 Participants
Alopecia Areata · Alopecia Totalis · Alopecia Universalis
Primary: Percent Change in Severity of Alopecia Tool (SALT) Score — 10 percent change
Alopecia Areata
Primary: Main Study: Number of Participants With Treatment Emergent Adverse Events (TEAEs) Until Follow-up Visit — 401; 515 Participants
Androgenetic Alopecia
Primary: Percentage Increase in Terminal Hair Counts From Pre-Treatment, Baseline for Active Test Subjects Over the Placebo Test Subjects. — 12.48; 63.67 percent change — p=<0.001
Female Pattern Hair Loss, Androgenic Alopecia
Primary: Change From Baseline in Investigator's Rating of Global Photographs at Week 12 — 4.9; 4.9; 4.8; 5.0 Score on a scale
Alopecia Areata
Primary: Change in Alopecia Areata Half Head Severity Score (AAHHSS) at 12 Weeks Compared to Baseline — -17.75 score on a scale
Androgenic Alopecia
Primary: Total Area Hair Count — 126.8 hairs per cm^2
Androgenetic Alopecia · Alopecia
Primary: Number of Participants With Improvement — 8; 1 Participants
Alopecia Areata
Primary: Total Number of Responders — 8 Participants